Type 1 Diabetes
Type 1 Diabetes (T1D) is an autoimmune disease where the immune system destroys insulin-producing cells in the pancreas, leading to high blood sugar levels, which require life-long insulin treatment. Common symptoms include frequent urination, increased thirst and hunger, weight loss, and tiredness, typically developing over a short period.
Health Outcomes
- Accelerated Immune Response Maturation
- Accelerated Oral Tolerance Development
- Altered Expression of Immune-Related Genes
- Altered Microbial Composition
- Altered T Cell Subsets
- Characterized Carbohydrate Metabolism Enzyme Activity
- Decreased Naïve CD45RA+ T Helper Cells
- Delayed Occurrence of CID
- Developed Islet Autoimmunity
- Developed Type 1 Diabetes
- Diabetes Progression
- Distinct Metabolic Profile
- Elevated BSA Antibody Levels
- Elevated Serum IL-2 Levels
- Enhanced Dendritic Cell-T Cell Interaction
- Enhanced Immune Cell Activity
- Enhanced Immune Function Post-Cessation
- Enhanced Immune Modulation
- Enhanced Immune Response
- Enhanced Immune Response Regulation
- Enhanced Immune System Function
- Enhanced Immunogenicity
- Enhanced Immunoregulatory Molecule Activity
- Enhanced Regulatory Immune System Development
- Enhanced Regulatory T Cell Development
- Enhanced Regulatory T Cell Function
- Enhanced T Cell Activation
- Enhanced T-Cell Proliferation
- Enhanced Treg Cell Differentiation
- Enhanced Type 1 Immune Response
- Improved Antigen Presentation
- Improved Beta-Cell Function
- Improved Blood Glucose Concentration
- Improved Blood Glucose Control
- Improved Blood Glucose Levels
- Improved Corneal Nerve Reflectivity
- Improved Dendritic Cell Activation
- Improved Diabetic Foot Ulcer Healing
- Improved Diabetic Retinopathy
- Improved Dialysis Adequacy
- Improved Fasting Plasma Glucose
- Improved Glucose Homeostasis
- Improved Glucose Level
- Improved Glucose Metabolism
- Improved Glucose Response
- Improved Glycemia
- Improved Glycemic Response
- Improved Hemoglobin A1c Levels
- Improved Hormonal Counter-Regulation
- Improved Humoral Immune Parameters
- Improved IgG Response to Vaccination
- Improved Immune Cell Counts
- Improved Immune Parameters
- Improved Immune Response to Vaccination
- Improved Immune System Activity
- Improved Immune System Function via JAK-STAT Pathway Activation
- Improved Immune Tolerance
- Improved Immunity Pathways
- Improved Immunity Status
- Improved Insulin Levels
- Improved Insulin Response
- Improved Medication Adherence
- Improved Metabolic Control in Type 1 Diabetes
- Improved Metabolic Homeostasis
- Improved Plasma Glucose Control
- Improved Regulatory T Cell Function
- Improved Retinal Function
- Improved Retinal Vascular Health
- Improved Retinopathy
- Improved Serum Glucose Levels
- Improved Serum Glycemia
- Improved Th1 Immunity
- Improved Treg/Th-17 Balance
- Increased Activation of Regulatory T Cells
- Increased Anion Gap
- Increased Apoptosis in T Cells
- Increased Beta-Hydroxybutyric Concentration
- Increased CD4+CD25+ T Cell Numbers
- Increased CD8 Percentage
- Increased Cytokine Production in Peripheral Blood Mononuclear Cells
- Increased Fat Oxidation
- Increased Foxp3 Protein Levels
- Increased Generation of T Regulatory Cells
- Increased Hyperkalemia
- Increased IFN-gamma Secretion from Naïve T Cells
- Increased Infection Frequency
- Increased Interleukin-2 Production
- Increased Memory T Cell Frequency
- Increased Natural Killer Cell Frequency
- Increased Plasma Glucagon Level
- Increased Proportion of Activated T Lymphocytes
- Increased Proportion with Normalized Hemoglobin A1c
- Increased Regulatory T Cell Count
- Increased Regulatory T Cell Expansion
- Increased Regulatory T Cell Frequency
- Increased Regulatory T Cell Response
- Increased Serum Glucose Levels
- Increased Serum Immunoglobulins
- Increased Specific Antibody Production
- Increased Splenic Lymphocyte Proliferation
- Increased Superoxide Dismutase Level
- Increased Systemic Antibody Production
- Increased T-cell Proliferation at 12 Months
- Increased T-helper Type 1 Cytokine Concentrations
- Increased Th1-Associated Cytokine Release
- Increased Treg Cell Fraction
- Increased Treg Frequency at 7 Days
- Increased Type I Interferon Production
- Increased Urinary Citrate Level
- Induced Th1 Cytokines
- Induction of Specific CD8+ T Cells
- Induction of Th1 Immune Response
- Influence on Metabolic Pathways
- Inhibited Absorption of Advanced Glycation End-products (AGEs)
- Lower Plasma Glucose Levels
- Maintained Glucose Control
- Modified Fetal Brain Metabolism
- Modified Serum Metabolomic Pathways
- Modulated Cytokine Levels
- Modulated Dendritic Cell Function
- Modulated Immune Function in Offspring
- Modulated Immune Tolerance
- Modulated Lymphocyte Populations
- Modulated Peripheral Immune Response
- Modulated Systemic Th1/Th2 Balance
- Modulated T Cell Response
- No Change in Body Weight or Food Consumption
- Preserved Beta-Cell Function
- Preserved Insulin-Secreting Beta Cells
- Preserved Islet Function
- Reduced Allograft Rejection
- Reduced Alpha-Amylase Activity
- Reduced B Cell Count in Draining Lymph Nodes
- Reduced Beta Cell Function
- Reduced Beta-Cell Loss
- Reduced Blood Glucose Level
- Reduced Blood HbA1c Levels
- Reduced Body Mass
- Reduced Body Mass Index
- Reduced CTLA-4 Expression on CD4 T Cells
- Reduced Candida Albicans Survival
- Reduced Contrast-Induced Acute Kidney Injury
- Reduced Contrast-Induced Nephropathy
- Reduced Day School Absenteeism
- Reduced Dendritic Cell Function
- Reduced Diabetic Complications
- Reduced Diabetic Ketoacidosis Incidence
- Reduced Diabetic Neuropathic Pain
- Reduced Disease Severity
- Reduced ER Stress Responses in β-cells
- Reduced Electrolyte Level
- Reduced Enzyme Activity Related to Diabetes
- Reduced Fasting Blood Glucose Levels
- Reduced Fecal Microbiota Diversity
- Reduced First Phase Insulin Secretion
- Reduced Glucagon Levels
- Reduced Glucose Area Under the Curve
- Reduced Glucose Level
- Reduced Glucose Levels
- Reduced Glucose Uptake
- Reduced Glycated Hemoglobin
- Reduced Glycated Hemoglobin A1c Level
- Reduced Glycation End Product Accumulation
- Reduced Glycative Stress Marker Level
- Reduced Glycemic Response
- Reduced Glycosylated Hemoglobin
- Reduced HOMA Index
- Reduced HbA1c Level
- Reduced Hemoglobin A1C Level
- Reduced Hepatic Glycogen Levels
- Reduced Hydrogen Sulfide Level
- Reduced Hyperglycemic Response
- Reduced Immune Cell Proliferation
- Reduced Inflammation in Dendritic Cells
- Reduced Inflammatory Cytokine Secretion from Activated T Cells
- Reduced Insulin Level
- Reduced Insulin Output (90-min)
- Reduced Insulin Requirement
- Reduced Islet β-Cell Dysfunction
- Reduced Mortality Risk
- Reduced Naïve CD45RA+ Th Cell Count
- Reduced Non-Infectious Complication Morbidity
- Reduced Pancreatic Inflammatory and Metabolic Dysregulation
- Reduced Pathogen Resistance
- Reduced Peripheral Neuropathy Grade
- Reduced Plasma Glucose Levels
- Reduced Postprandial Blood Glucose Rise
- Reduced Preproinsulin-Specific CD8+ T-Cell Frequency
- Reduced Pro-inflammatory Cytokine Release
- Reduced Proliferation of CD4(+) T Cells
- Reduced Protein Glycation
- Reduced Recovery Time After Surgery
- Reduced Risk Factors for Multiple Sclerosis
- Reduced Serum Glucose Levels
- Reduced Serum Interferon Gamma
- Reduced T Cell Proliferation
- Reduced Thymus and Activation-Regulated Chemokine Level
- Reduced Total Glycated Hemoglobin
- Reduced Total Human Milk Oligosaccharide Concentration
- Reduced Urinary Albumin
- Reduced Weight Gain and Fat Mass
- Reduced Wound Area
- Reduced Zonulin Level
- Regulated Blood Glucose Levels
- Regulated Carbohydrate Metabolism Enzyme Level
- Regulated Cytokine Levels
- Remodeled Intestinal Microbiota
- Restored Regulatory T Cell Population
- Restored Th1/Th2 Cytokine Balance
- Restored Treg Cell Population in MLNs
- Retina Protection
- Stabilized Blood Glucose Level
- Stabilized Hemoglobin A1c Level
- Stable Antihyperglycemic Effect
- Stable Fasting Plasma Glucose
- Stable Glucose Metabolism Markers
- Stable Immune System Responses
- Sustained Immune Function
- Th1 Polarized Immune Response Through Activation of moDCs
- Unchanged Glycemic Control
- Unchanged Growth Parameters
- Worsened Acidosis
- Worsened Autoimmune Manifestations